| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc. | EVP Clinical Development | Stock Option (Right to Buy) | 0 | 27 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PNT | POINT Biopharma Global Inc. | 27 Dec 2023 | 5 | $0 | 4 | EVP Clinical Development | 27 Dec 2023, 17:39 |
| PNT | POINT Biopharma Global Inc. | 28 Mar 2023 | 1 | $0 | 4 | EVP Clinical Development | 30 Mar 2023, 20:08 |
| PNT | POINT Biopharma Global Inc. | 01 Apr 2022 | 1 | $0 | 4 | EVP Clinical Development | 05 Apr 2022, 10:48 |
| PNT | POINT Biopharma Global Inc. | 29 Mar 2022 | 1 | $0 | 4 | EVP Clinical Development | 31 Mar 2022, 17:01 |
| PNT | POINT Biopharma Global Inc. | 06 Jul 2021 | 1 | $0 | 4 | EVP Clinical Development | 08 Jul 2021, 16:37 |
| PNT | POINT Biopharma Global Inc. | 30 Jun 2021 | 1 | $0 | 4 | EVP Clinical Development | 30 Jun 2021, 21:30 |
| PNT | POINT Biopharma Global Inc. | 30 Jun 2021 | 0 | $0 | 3 | EVP Clinical Development | 30 Jun 2021, 21:21 |